Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

<p>Abstract</p> <p>Background</p> <p>Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4<sup>+</sup> T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medic...

Full description

Bibliographic Details
Main Authors: Sempa Joseph, Ssennono Mark, Kuznik Andreas, Lamorde Mohammed, Sowinski Stefanie, Semeere Aggrey, Hermans Sabine, Castelnuovo Barbara, Manabe Yukari C
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Public Health
Subjects:
HAART
Economics
Mortality
Adverse effects
Online Access:http://www.biomedcentral.com/1471-2458/12/736

Similar Items

Similar Items